[go: up one dir, main page]

ZA200708700B - Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) - Google Patents

Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)

Info

Publication number
ZA200708700B
ZA200708700B ZA200708700A ZA200708700A ZA200708700B ZA 200708700 B ZA200708700 B ZA 200708700B ZA 200708700 A ZA200708700 A ZA 200708700A ZA 200708700 A ZA200708700 A ZA 200708700A ZA 200708700 B ZA200708700 B ZA 200708700B
Authority
ZA
South Africa
Prior art keywords
tfpi
administration
treatment
tissue factor
pathway inhibitor
Prior art date
Application number
ZA200708700A
Other languages
English (en)
Inventor
Creasey Abla
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of ZA200708700B publication Critical patent/ZA200708700B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200708700A 2005-04-15 2008-10-11 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) ZA200708700B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67146605P 2005-04-15 2005-04-15

Publications (1)

Publication Number Publication Date
ZA200708700B true ZA200708700B (en) 2008-12-31

Family

ID=36951247

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200708700A ZA200708700B (en) 2005-04-15 2008-10-11 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)

Country Status (13)

Country Link
EP (1) EP1871408A2 (xx)
JP (1) JP2008536859A (xx)
KR (1) KR20080033151A (xx)
CN (1) CN101180074A (xx)
AU (1) AU2006236698A1 (xx)
BR (1) BRPI0610549A2 (xx)
CA (1) CA2605057A1 (xx)
IL (1) IL186548A0 (xx)
MX (1) MX2007012619A (xx)
RU (1) RU2007142192A (xx)
TN (1) TNSN07386A1 (xx)
WO (1) WO2006113360A2 (xx)
ZA (1) ZA200708700B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009129164A1 (en) * 2008-04-15 2009-10-22 Novartis Ag Pharmaceutical combinations of tfpi-fragments and an antibiotic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200400549A1 (ru) * 2001-10-15 2005-02-24 Чирон Корпорейшн Лечение сепсиса введением малых доз ингибитора пути тканевого фактора (tfpi)

Also Published As

Publication number Publication date
AU2006236698A1 (en) 2006-10-26
JP2008536859A (ja) 2008-09-11
BRPI0610549A2 (pt) 2010-07-06
CA2605057A1 (en) 2006-10-26
EP1871408A2 (en) 2008-01-02
IL186548A0 (en) 2008-01-20
CN101180074A (zh) 2008-05-14
WO2006113360A3 (en) 2007-04-12
TNSN07386A1 (en) 2009-03-17
MX2007012619A (es) 2008-01-11
KR20080033151A (ko) 2008-04-16
RU2007142192A (ru) 2009-05-20
WO2006113360A2 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
IL250640A0 (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
ZA200709520B (en) Use of TFPI to treat severe bacterial infections
WO2007135527A3 (en) Benzimidazolyl compounds
EP2049137A4 (en) SALICYLANILIDES AS AMPLIFIERS OF THE ORAL RELEASE OF THERAPEUTIC PEPTIDES
ZA200902270B (en) Hydrobenzamide derivatives as inhibitors of hsp90
ZA200704392B (en) Antibiotic combinations for providing total solution to the treatment of infections
IL193252A0 (en) N-hydroxyacrylamide compounds
WO2008026156A3 (en) Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor
NO20085051L (no) Behandling av gastrointestinale forstyrrelser med CGRP-antagonister
HUP0501111A2 (en) Treatment of severe pneumonia by administration of tissue factor pathway inhibitor
EP1954298A4 (en) DISPENSING SYSTEM FOR ORAL THERAPEUTIC CONNECTION
DK1837019T3 (da) Orale dispergerbare farmaceutiske sammensætninger
IL182055A0 (en) Agent for prophylaxis or treatment of metabolic syndrome
ZA200708700B (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)
IL178115A0 (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)
HK1107770A (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi)
HK1097198A (en) Treatment of severe community-acquired pneumonia by admistration of tissue factor pathway inhibitor (tfpi)
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
WO2007139948A3 (en) Imidazoazepinone compounds
HK1108376A (en) Use of tfpi to treat severe bacterial infections
MA30730B1 (fr) Traitement de la pneumonie extra-hospitaliere grave par administration de l'inhibiteur de parcours de facteur tissu (tfpi)
AU2006905588A0 (en) "Rake n' scrub" medical treatment
HK1106696A (en) Agent for prophylaxis or treatment of metabolic syndrome
TWI350171B (en) Pharmaceutical compositions for treatment of cardio-cerebral-vascular diseases
ITMI20020755A1 (it) Composizioni farmaceutica topica per il trattamento della scabbia